Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways.
about
SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylationMDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activityTomosyn interacts with the SUMO E3 ligase PIASγ.A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific.SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stressSilencing nuclear pore protein Tpr elicits a senescent-like phenotype in cancer cellsp53 post-translational modification: deregulated in tumorigenesisInterleukin-32α downregulates the activity of the B-cell CLL/lymphoma 6 protein by inhibiting protein kinase Cε-dependent SUMO-2 modification.The transcriptional cofactor MCAF1/ATF7IP is involved in histone gene expression and cellular senescenceTP53 status and response to treatment in breast cancersFAT10 modifies p53 and upregulates its transcriptional activity.SUMOylation of DLX3 by SUMO1 promotes its transcriptional activity.SUMOhunt: Combining Spatial Staging between Lysine and SUMO with Random Forests to Predict SUMOylation.RhoA-mediated signaling in Notch-induced senescence-like growth arrest and endothelial barrier dysfunction.Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2H.Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalanceThe in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs.Oxidative stress response and Nrf2 signaling in aging.SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylaseCoping with stress: multiple ways to activate p53.Overexpression of SENP3 in oral squamous cell carcinoma and its association with differentiation.PML, SUMOylation, and SenescenceRepression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts.Sumo-2/3-ylation following in vitro modeled ischemia is reduced in delayed ischemic tolerance.Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function.Pc2-mediated SUMOylation of WWOX is essential for its suppression of DU145 prostate tumorigenesis.KSHV latent protein LANA2 inhibits sumo2 modification of p53.SUMOylation of p53 mediates interferon activitiesSUMO and the robustness of cancer.The SUMOylation of zinc-fingers and homeoboxes 1 (ZHX1) by Ubc9 regulates its stability and transcriptional repression activity.SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia.Kaposi's sarcoma-associated herpesvirus lana2 protein interacts with the pocket proteins and inhibits their sumoylation.Modification of Drosophila p53 by SUMO modulates its transactivation and pro-apoptotic functions.Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase.Simultaneous measurement of SUMOylation using SNAP/CLIP-tag-mediated translation at the single-molecule level.In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells.Desumoylase SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway.The Role of Sumoylation in Senescence.
P2860
Q24328747-3CA1E844-35F0-47F1-B1C2-C902A74D71DFQ28118946-974D26F4-64A4-4DD0-8B79-BC929B3B6BDFQ31153788-56846A8A-0EE2-4CBB-A212-7CFE9F6B7FA9Q33596988-AD079A1A-883D-43F7-B364-96525D7A5BE3Q33648307-6576783D-9673-40D6-8718-59A1AD301F71Q33800141-73E81CDA-D222-4895-AA12-18260E0947FAQ33979961-FD4CA534-E106-4C04-80DD-F78D91647943Q34300569-73B09A5F-BB95-467A-B85D-FC14C854C422Q34483769-6F0A2055-8268-456A-8C6C-0DDCC364447EQ34918305-9C2ADB63-C813-4C02-A88F-A4D9EC337F7AQ35043933-44F65F22-9EC0-49B0-B969-4C72D7442D10Q35097418-888AE008-4CE8-4C1F-859F-950E16C40ADAQ35234133-6B3B8C63-792D-44BD-B6A3-27CEDAE304C8Q35362103-ABB41B81-77CE-42DD-B8BC-B20FEC0CC515Q35657354-4B2EFAE5-3008-4F92-84D6-6737C607EFE8Q35913673-289A8A24-320E-49B4-9A50-D686F6C7A3CCQ35946259-52183B2B-5C95-483E-B579-4BB8E4DA383DQ36225738-1485800A-9EA3-42CC-8BAC-5A6232CBF9FEQ36236785-967187A1-DD3E-44C7-BAD8-46A0FEDBFEB9Q36278928-3AF5DB5A-DE82-4CF7-9FE4-2E41FC0335E1Q36745375-8AE03F63-A3EB-4E07-8E7B-F570E3141D47Q36858606-EAED622D-EBBA-49C9-B086-7B5DB4FED6A2Q36981640-6782CCCF-D3B6-48C9-97A0-3D368C01D3D4Q37349403-0711A2E3-DADC-49BC-B70C-C2FF67387D11Q37415135-FB8EBE15-A4E4-4A8C-AC01-5335E0DB8D9AQ38103250-F5DC82DF-E030-4543-876F-D18FC46B22B9Q38817885-0539F54B-B2F5-4DAF-8FE9-36A80562B8FBQ38917974-C34B8823-FF82-4BAE-A081-41A3EC04B300Q39106989-1DD95E8E-667F-4D36-8A6C-376491F97FD3Q39108925-87281142-25E0-4A72-A025-FFE5670A195BQ39149819-67FE2D65-8BCA-48EF-AB78-078314C7285EQ39176491-DE27711F-64A5-4163-A924-E563A822D303Q39210824-4FF1D3FD-5DDF-4B2E-9603-829F9CA7A86FQ40423291-B4CB3905-0406-47DF-871F-A516DC808F0DQ42086146-B408B0F3-A39D-4C54-8F3B-59DF33A23C9BQ42408048-742E556A-43AA-44CF-A5A8-B75253DE3D3CQ46343177-014C7908-6EEC-4FBF-BE45-CA720E6516F7Q47384716-60A09B63-7867-48A6-9FC3-5FDD920ADAC3Q48267805-39FF5972-EB7F-45C8-81FD-9F15B593D155Q51137583-461B45DC-A7F7-4499-80DA-E56F44C67266
P2860
Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways.
@en
Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways.
@nl
type
label
Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways.
@en
Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways.
@nl
prefLabel
Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways.
@en
Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways.
@nl
P2093
P2860
P356
P1476
Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways.
@en
P2093
David C H Yang
Ephrem Tekle
Guanghui Wang
P Boon Chock
Rasa Santockyte
Rong-Fong Shen
Tianwei Li
P2860
P304
36221-36227
P356
10.1074/JBC.M608236200
P407
P577
2006-09-29T00:00:00Z